Loading...

NSPR INSPIREMD INC Product Launches 8-K Filing

NSPR

NSPR

INSPIREMD INC

(NSPR)

2026 8-K

Financial Results Released

Recall and Approval

New Equity Offering

Financial Results Announced

Management Change

Director Resignation

Financial Results Update

Management Change

Financial Statements

Equity Offerings

New Product Launches

Pre-Market Approval

Pre-Market Approval

Financial Statements

Financial Results

Clinical Trial Update

Board Appointment

Earnings Announcement

New Headquarters

Inducement Plan

FDA Approval Application

Earnings Reports

Investor Presentation

Annual Meeting Voting Results

Equity Distribution Agreement

Earnings Reports

Amendment of Employment Agr...

Earnings Reports

CE Mark Recertification

Patent Issuance

Strategic Agreement

Earnings Reports

Clinical Trial Results

Reappointment of Officers

Earnings Reports

Completion of Enrollment in...

Investor Presentation

Earnings Reports

Securities Purchase Agreement

Earnings Reports

Promotion of Andrea Tommaso...

External Links:

On May 1, 2026, InspireMD, Inc. announced a voluntary recall of its CGuard Prime 135 cm carotid stent delivery system due to unmet performance expectations. Additionally, the FDA approved their IDE application for the CGUARDIANS III study of the SwitchGuard neuro protection system for use with the CGuard Prime 80 cm stent.

AI Assistant

INSPIREMD INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.